1	Transcription	Transcription	_	_	_	_	_	_	_
2	factor	factor	_	_	_	_	_	_	_
3	GATA-3	gata-3	_	_	_	_	_	_	_
4	is	be	_	_	_	_	_	_	_
5	differentially	differentially	_	_	_	_	_	_	_
6	expressed	express	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	murine	murine	_	_	_	_	_	_	_
9	Th1	th1	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	Th2	th2	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	controls	control	_	_	_	_	_	_	_
15	Th2-specific	th2-specific	_	_	_	_	_	_	_
16	expression	expression	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	interleukin-5	interleukin-5	_	_	_	_	_	_	_
20	gene	gene	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Interleukin-5	Interleukin-5	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	IL-5	IL-5	_	_	_	_	_	_	_
4	)	)	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	which	which	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	produced	produce	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	CD4(+)	cd4(+)	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	helper	helper	_	_	_	_	_	_	_
13	2	2	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	Th2	th2	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	but	but	_	_	_	_	_	_	_
20	not	not	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	Th1	th1	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	plays	play	_	_	_	_	_	_	_
26	a	a	_	_	_	_	_	_	_
27	key	key	_	_	_	_	_	_	_
28	role	role	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	development	development	_	_	_	_	_	_	_
32	of	of	_	_	_	_	_	_	_
33	eosinophilia	eosinophilia	_	_	_	_	_	_	_
34	in	in	_	_	_	_	_	_	_
35	asthma	asthma	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	Despite	despite	_	_	_	_	_	_	_
2	increasing	increase	_	_	_	_	_	_	_
3	evidence	evidence	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	outcome	outcome	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	many	many	_	_	_	_	_	_	_
9	diseases	disease	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	determined	determine	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	ratio	ratio	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	two	two	_	_	_	_	_	_	_
18	subsets	subset	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	CD4(+)	cd4(+)	_	_	_	_	_	_	_
21	T	t	_	_	_	_	_	_	_
22	helper	helper	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	Th1	Th1	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	Th2	Th2	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	molecular	molecular	_	_	_	_	_	_	_
31	basis	basis	_	_	_	_	_	_	_
32	for	for	_	_	_	_	_	_	_
33	Th1-	Th1-	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	Th2-	th2-	_	_	_	_	_	_	_
36	specific	specific	_	_	_	_	_	_	_
37	gene	gene	_	_	_	_	_	_	_
38	expression	expression	_	_	_	_	_	_	_
39	remains	remain	_	_	_	_	_	_	_
40	to	to	_	_	_	_	_	_	_
41	be	be	_	_	_	_	_	_	_
42	elucidated	elucidate	_	_	_	_	_	_	_
43	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	previously	previously	_	_	_	_	_	_	_
3	established	establish	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	critical	critical	_	_	_	_	_	_	_
6	role	role	_	_	_	_	_	_	_
7	for	for	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	transcription	transcription	_	_	_	_	_	_	_
10	factor	factor	_	_	_	_	_	_	_
11	GATA-3	gata-3	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	IL-5	IL-5	_	_	_	_	_	_	_
14	promoter	promoter	_	_	_	_	_	_	_
15	activation	activation	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	EL-4	el-4	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	which	which	_	_	_	_	_	_	_
21	express	express	_	_	_	_	_	_	_
22	both	both	_	_	_	_	_	_	_
23	Th1-	th1-	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	Th2-type	th2-type	_	_	_	_	_	_	_
26	cytokines	cytokine	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	reported	report	_	_	_	_	_	_	_
4	here	here	_	_	_	_	_	_	_
5	demonstrate	demonstrate	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	GATA-3	gata-3	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	critical	critical	_	_	_	_	_	_	_
10	for	for	_	_	_	_	_	_	_
11	expression	expression	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	IL-5	il-5	_	_	_	_	_	_	_
15	gene	gene	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	bona	bona	_	_	_	_	_	_	_
18	fide	fide	_	_	_	_	_	_	_
19	Th2	th2	_	_	_	_	_	_	_
20	cells	cell	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Whereas	whereas	_	_	_	_	_	_	_
2	mutations	mutation	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	GATA-3	gata-3	_	_	_	_	_	_	_
6	site	site	_	_	_	_	_	_	_
7	abolished	abolish	_	_	_	_	_	_	_
8	antigen-	antigen-	_	_	_	_	_	_	_
9	or	or	_	_	_	_	_	_	_
10	cAMP-	camp-	_	_	_	_	_	_	_
11	stimulated	stimulate	_	_	_	_	_	_	_
12	IL-5	il-5	_	_	_	_	_	_	_
13	promoter	promoter	_	_	_	_	_	_	_
14	activation	activation	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	Th2	th2	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	ectopic	ectopic	_	_	_	_	_	_	_
20	expression	expression	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	GATA-3	gata-3	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	Th1	th1	_	_	_	_	_	_	_
25	cells	cell	_	_	_	_	_	_	_
26	or	or	_	_	_	_	_	_	_
27	in	in	_	_	_	_	_	_	_
28	a	a	_	_	_	_	_	_	_
29	non-lymphoid	non-lymphoid	_	_	_	_	_	_	_
30	,	,	_	_	_	_	_	_	_
31	non-IL-5-producing	non-il-5-producing	_	_	_	_	_	_	_
32	cell	cell	_	_	_	_	_	_	_
33	line	line	_	_	_	_	_	_	_
34	activated	activate	_	_	_	_	_	_	_
35	the	the	_	_	_	_	_	_	_
36	IL-5	il-5	_	_	_	_	_	_	_
37	promoter	promoter	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	During	during	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	differentiation	differentiation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	naive	naive	_	_	_	_	_	_	_
6	CD4(+)	cd4(+)	_	_	_	_	_	_	_
7	T	t	_	_	_	_	_	_	_
8	cells	cell	_	_	_	_	_	_	_
9	isolated	isolate	_	_	_	_	_	_	_
10	from	from	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	cell	cell	_	_	_	_	_	_	_
13	receptor	receptor	_	_	_	_	_	_	_
14	transgenic	transgenic	_	_	_	_	_	_	_
15	mice	mouse	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	GATA-3	gata-3	_	_	_	_	_	_	_
18	gene	gene	_	_	_	_	_	_	_
19	expression	expression	_	_	_	_	_	_	_
20	was	be	_	_	_	_	_	_	_
21	up-regulated	up-regulate	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	developing	develop	_	_	_	_	_	_	_
24	Th2	th2	_	_	_	_	_	_	_
25	cells	cell	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	but	but	_	_	_	_	_	_	_
28	was	be	_	_	_	_	_	_	_
29	down-regulated	down-regulate	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	Th1	th1	_	_	_	_	_	_	_
32	cells	cell	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	antigen-	antigen-	_	_	_	_	_	_	_
36	or	or	_	_	_	_	_	_	_
37	cAMP-activated	camp-activated	_	_	_	_	_	_	_
38	Th2	th2	_	_	_	_	_	_	_
39	cells	cell	_	_	_	_	_	_	_
40	(	(	_	_	_	_	_	_	_
41	but	but	_	_	_	_	_	_	_
42	not	not	_	_	_	_	_	_	_
43	Th1	th1	_	_	_	_	_	_	_
44	cells	cell	_	_	_	_	_	_	_
45	)	)	_	_	_	_	_	_	_
46	expressed	express	_	_	_	_	_	_	_
47	the	the	_	_	_	_	_	_	_
48	GATA-3	gata-3	_	_	_	_	_	_	_
49	protein	protein	_	_	_	_	_	_	_
50	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	GATA-3	GATA-3	_	_	_	_	_	_	_
4	may	may	_	_	_	_	_	_	_
5	play	play	_	_	_	_	_	_	_
6	an	an	_	_	_	_	_	_	_
7	important	important	_	_	_	_	_	_	_
8	role	role	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	balance	balance	_	_	_	_	_	_	_
12	between	between	_	_	_	_	_	_	_
13	Th1	th1	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	Th2	th2	_	_	_	_	_	_	_
16	subsets	subset	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	immune	immune	_	_	_	_	_	_	_
19	responses	response	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Inhibition	Inhibition	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	GATA-3	GATA-3	_	_	_	_	_	_	_
4	activity	activity	_	_	_	_	_	_	_
5	has	have	_	_	_	_	_	_	_
6	therapeutic	therapeutic	_	_	_	_	_	_	_
7	potential	potential	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	treatment	treatment	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	asthma	asthma	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	other	other	_	_	_	_	_	_	_
15	hypereosinophilic	hypereosinophilic	_	_	_	_	_	_	_
16	diseases	disease	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

